---
$id: https://graph.org.ai/products/commodity/51171964
$type: Product
source: UNSPSC
code: "51171964"
title: "Sufotidine"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sufotidine

**UNSPSC Code**: 51171964
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-2 receptor antagonist with the molecular formula C20H31N5O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 56B0591Y76, chemically known as 1-(m-(3-((1-methyl-3-((methylsulfonyl)methyl)-1h-1,2,4-triazol-5-yl)amino)propoxy)benzyl)piperidine but generally known as sufotidine, which bears US NIH Compound Identifier 71763. European Medicines Agency schedules Sufotidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10673MIG. The term SUFOTIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). SUFOTIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sufotidine under HS 29333999 and SITC 51574. As of Q4 2014, SUFOTIDINE remains the US FDA Preferred Term for this commodity. Sufotidine bears US NLM identifiers UMLS ID C0075495 and NCI Concept Code C73217. SMILES: S(=O)(=O)(CC1NC(NCCCOC2CC(CN3CCCCC3)CCC2)N(N1)C)C.

